Volume 11, Number 6—June 2005
Research
Community-associated Methicillin-resistant Staphylococcus aureus in Hospital Nursery and Maternity Units
Table 1
Patient | Age at onset | Sex | Strain | Infection type | Initial therapy | Definitive therapy |
---|---|---|---|---|---|---|
P1, newborn | 8 d | F | USA 400 | Preseptal cellulitis | Nafcillin, cefotaxime | Topical gentamicin |
P2, newborn | 13 d | F | USA 400 | Omphalitis, otitis externa | Ampicillin, cefotaxime | Topical mupirocin |
P3, mother | 33 y | F | USA 400 | Breast abscess | Cefazolin | Surgical drainage, vancomycin, topical mupirocin |
P4, newborn | 2 d | M | USA 400 | Omphalitis, pustulosis | Nafcillin Gentamicin | Gentamicin, topical mupirocin |
P5, newborn | 4 d | M | USA 400 | Pustulosis | Cephalexin | Topical bacitracin |
P6, newborn | 2 d | M | USA 400 | Pustulosis | None | Local wound care |
P7, newborn | 1 d | F | USA 400 | Pustulosis, mastitis | Topical mupirocin | Vancomycin |
P8, mother | 24 y | F | Unique | Peripheral IV catheter site | Cefazolin | Trimethoprim-sulfamethoxazole, catheter removal |
Page created: April 24, 2012
Page updated: April 24, 2012
Page reviewed: April 24, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.